• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    US Urinary incontinence Market

    ID: MRFR/MED/11942-HCR
    100 Pages
    Garvit Vyas
    September 2025

    US Urinary Incontinence Market Research Report By Type (Urge incontinence, Stress Incontinence, Overflow incontinence, Functional incontinence) and By Devices (Electrical Stimulation Devices, Foley Catheters, Antimicrobial Foley Catheters, Urethral Bulking Agents) - Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    US Urinary incontinence Market Research Report — Global Forecast till 2035 Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Table of Contents

    US Urinary incontinence Market Summary

    The US Urinary Incontinence market is projected to grow from 2.9 USD Billion in 2024 to 5.8 USD Billion by 2035.

    Key Market Trends & Highlights

    US Urinary Incontinence Key Trends and Highlights

    • The market is expected to achieve a compound annual growth rate (CAGR) of 6.5 percent from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 5.8 USD Billion, indicating robust growth potential.
    • In 2024, the market is valued at 2.9 USD Billion, reflecting the current demand for urinary incontinence solutions.
    • Growing adoption of innovative treatment options due to increasing awareness of urinary incontinence is a major market driver.

    Market Size & Forecast

    2024 Market Size 2.9 (USD Billion)
    2035 Market Size 5.8 (USD Billion)
    CAGR (2025-2035) 6.5%

    Major Players

    UroLift, Hollister Incorporated, Johnson and Johnson, Coloplast, Convatec, Stryker Corporation, Astellas Pharma, Abbott Laboratories, B Braun, ConvaTec, Boston Scientific, Sofradim Production, Medtronic, Baxter International, C.R. Bard

    US Urinary incontinence Market Trends

    The US Urinary Incontinence Market is witnessing significant trends driven by an aging population and increasing awareness of urinary incontinence as a health issue. As the population over 65 continues to rise, more individuals experience urinary incontinence. According to government health statistics, approximately 50% of older adults encounter this condition, revealing a pressing need for effective management options.

    This demographic shift is a key market driver, leading to heightened demand for innovative treatment solutions and products, such as absorbent briefs and pelvic floor training devices. Furthermore, advancements in technology are shaping recent trends. This includes the integration of smart technologies in urinary incontinence products, offering users enhanced tracking and management capabilities.

    Many companies are leveraging telemedicine to provide remote consultations, improving accessibility for patients unable to visit clinics. This trend aligns with the overall movement toward digital health, as patients increasingly seek convenient, at-home approaches for managing their health. Opportunities in the US market also abound, especially for manufacturers willing to invest in research and development.

    Developing more comfortable, discreet, and technologically advanced products can cater to the needs of the growing customer base. Additionally, marketing efforts that focus on reducing stigma and promoting open discussions around urinary incontinence can further capture interest and drive sales. Overall, the trends in the US Urinary Incontinence Market reflect a convergence of demographic shifts, technological innovations, and the pursuit of better quality of life for individuals facing this common condition.

    US Urinary incontinence Market Drivers

    Market Segment Insights

    Urinary Incontinence Market Type Insights

    The US Urinary Incontinence Market exhibits a rich and intricate landscape characterized by various types of incontinence, each with unique implications for patient care and treatment approaches. The segment is categorized mainly into Urge incontinence, Stress incontinence, Overflow incontinence, and Functional incontinence, with each type representing a distinct clinical presentation and underlying cause.

    Urge incontinence is particularly noteworthy due to its prevalence in the aging population, often driven by neurological factors or bladder overactivity, indicating a pressing need for effective management solutions. Stress incontinence, on the other hand, is significant, especially among women, as it commonly results from pelvic floor weakening after childbirth or menopause, highlighting the importance of pelvic health awareness and rehabilitative practices.

    Overflow incontinence is more common in men and can often be linked to prostate conditions, necessitating targeted treatment strategies and healthcare education. Lastly, Functional incontinence arises from physical and cognitive impairments that prevent individuals from reaching the bathroom on time, which can happen in the elderly and those with disabilities, emphasizing the need for comprehensive patient support systems that consider mobility and cognitive factors.

    As the population continues to age, the demand for tailored therapeutic solutions in the US Urinary Incontinence Market will likely expand, reflecting broader trends in healthcare focused on improving quality of life for patients. The growth and evolution of this market segment are driven by an increasing awareness of urinary health and advancements in treatment technologies, alongside the socio-economic challenges faced by an aging population.

    Key trends indicate a shift towards minimally invasive treatment options and a growing emphasis on patient education and empowerment, which could improve treatment adherence and overall outcomes. The challenges remain, however, in overcoming stigmas surrounding urinary incontinence, which can inhibit individuals from seeking the necessary care. Recognizing the complexities surrounding each type of incontinence is essential not just for healthcare providers but also for policymakers aiming at developing effective interventions to address this widespread but often underreported health concern.

    Urinary Incontinence Market Devices Insights

    The Devices segment of the US Urinary Incontinence Market plays a crucial role in addressing the challenges faced by individuals suffering from urinary incontinence. This market is characterized by various product categories, including Electrical Stimulation Devices, Foley Catheters, Antimicrobial Foley Catheters, and Urethral Bulking Agents, each serving unique purposes.

    Electrical Stimulation Devices are significant for their ability to provide non-invasive treatment options, helping to improve bladder control and reduce the frequency of incontinence episodes. Foley Catheters dominate due to their widespread application for patients requiring temporary urinary drainage, particularly in clinical settings.

    The introduction of Antimicrobial Foley Catheters has revolutionized infection prevention strategies, significantly reducing the risk of catheter-associated urinary tract infectionsa critical concern in healthcare. Additionally, Urethral Bulking Agents are pivotal as they offer a minimally invasive solution aimed at treating stress urinary incontinence by enhancing urethral closure.

    As the US faces an increasing aging population, coupled with a growing awareness regarding urinary health, the demand for innovative and effective devices to manage urinary incontinence continues to grow, driving substantial advancements and market growth.

    Get more detailed insights about US Urinary incontinence Market Research Report — Global Forecast till 2035

    Regional Insights

    Key Players and Competitive Insights

    The US Urinary Incontinence Market is characterized by a thriving landscape, driven by an increasing prevalence of urinary incontinence among the aging population, changing lifestyles, and a growing awareness of treatment options. This market is multifaceted, comprising a range of products including over-the-counter solutions, surgical interventions, and specialized devices, which offer a plethora of options for patients suffering from this condition.

    As healthcare providers and manufacturers work to advance their offerings, the competition intensifies, leading to innovative solutions and improved patient outcomes. Key players are focusing on strategic initiatives such as product development, mergers, acquisitions, and partnerships to enhance their market presence and deliver value-added services to patients and healthcare practitioners alike. A closer examination of specific companies reveals the dynamics of competition within this market space.

    UroLift has positioned itself as a key player in the US Urinary Incontinence Market by offering a minimally invasive treatment option for men experiencing urinary symptoms associated with an enlarged prostate. The UroLift procedure differentiates itself through its unique fixation system that alleviates symptoms without significant intervention, appealing to a demographic that often seeks less invasive solutions.

    The company's existing presence in the market is bolstered by strategic educational initiatives that help healthcare providers understand the benefits of UroLift for patients, thus promoting wider adoption. With a commitment to innovation, UroLift continuously seeks enhancements to its technology and reinforces its competitive edge through clinical studies that validate its efficacy and safety, contributing to its strong positioning among competitors in the urinary incontinence treatment domain.

    Hollister Incorporated has a strong foothold in the US Urinary Incontinence Market, predominantly recognized for its comprehensive portfolio of healthcare products that cater to individuals dealing with various aspects of urinary incontinence. The company's offerings include innovative pouches, catheters, and a range of skin care products designed to improve comfort and quality of life for users.

    Hollister's reputation is further strengthened by its dedication to research and development, leading to the introduction of cutting-edge technologies that address patient needs effectively. The company actively engages in merging and acquisition strategies to broaden its product reach and functionality, ensuring it remains a formidable player in the market.

    Through its extensive distribution network and a strong commitment to education and support for healthcare providers and patients alike, Hollister Incorporated exemplifies a well-rounded approach in addressing the challenges associated with urinary incontinence, thereby enhancing its competitive landscape in the US market.

    Key Companies in the US Urinary incontinence Market market include

    Industry Developments

    In recent months, the US Urinary Incontinence Market has witnessed notable developments, driven by increased awareness and shifting demographics. Companies such as UroLift and Boston Scientific are launching innovative treatment options that offer minimally invasive solutions, contributing to enhanced patient satisfaction. In August 2023, Hollister Incorporated announced an expansion of its product line focused on urinary management, demonstrating a commitment to improving quality of life for patients.

    Significant growth has been noted in the market valuation of firms, especially as awareness surrounding urinary incontinence increases and more people seek treatment, highlighting a market growth trend that reflects a projected CAGR over the coming years. In terms of mergers, in September 2023, Convatec successfully acquired a smaller competitor, further strengthening its position in the urinary care segment.

    Furthermore, the ongoing research and development initiatives by Astellas Pharma and Medtronic continue to add to the landscape of available treatment options aiming to address urinary incontinence. The US market is also seeing a rise in telehealth consultations, facilitating broader access to care. Overall, the market is evolving rapidly, marked by innovation, strategic partnerships, and increased consumer demand for reliable treatment options.

    Market Segmentation

    Urinary Incontinence Market Type Outlook

    • Urge incontinence
    • Stress Incontinence
    • Overflow incontinence
    • Functional incontinence

    Urinary Incontinence Market Devices Outlook

    • Electrical Stimulation Devices
    • Foley Catheters
    • Antimicrobial Foley Catheters
    • Urethral Bulking Agents

    Report Scope

    Report Attribute/Metric Source: Details
    MARKET SIZE 2018 2.53(USD Billion)
    MARKET SIZE 2024 2.9(USD Billion)
    MARKET SIZE 2035 5.8(USD Billion)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 6.504% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Billion
    KEY COMPANIES PROFILED UroLift, Hollister Incorporated, Johnson and Johnson, Coloplast, Convatec, Stryker Corporation, Astellas Pharma, Abbott Laboratories, B Braun, ConvaTec, Boston Scientific, Sofradim Production, Medtronic, Baxter International, C.R. Bard
    SEGMENTS COVERED Type, Devices
    KEY MARKET OPPORTUNITIES Telehealth solutions for remote care, Advanced wearable devices for monitoring, Innovative absorbent product designs, Growth in geriatric population, Increased awareness and education programs
    KEY MARKET DYNAMICS rising elderly population, increasing awareness and diagnosis, advancements in treatment options, growing demand for disposable products, impact of chronic diseases
    COUNTRIES COVERED US

    Market Highlights

    Author
    Garvit Vyas
    Analyst

    Explore the profile of Garvit Vyas, one of our esteemed authors at Market Research Future, and access their expert research contributions in the field of market research and industry analysis

    Leave a Comment

    FAQs

    What is the expected market size of the US Urinary Incontinence Market in 2024?

    The expected market size of the US Urinary Incontinence Market in 2024 is valued at 2.9 billion USD.

    What will be the projected market value of the US Urinary Incontinence Market by 2035?

    The projected market value of the US Urinary Incontinence Market by 2035 is anticipated to reach 5.8 billion USD.

    What is the expected compound annual growth rate (CAGR) for the US Urinary Incontinence Market from 2025 to 2035?

    The expected CAGR for the US Urinary Incontinence Market from 2025 to 2035 is 6.504%.

    Which segment holds the largest share within the US Urinary Incontinence Market?

    Urge incontinence is projected to hold a significant share of the US Urinary Incontinence Market, valued at 0.744 billion USD in 2024.

    What is the market value of stress incontinence in the US Urinary Incontinence Market for 2024?

    The market value for stress incontinence in the US Urinary Incontinence Market is forecasted to be 0.892 billion USD in 2024.

    What are the key players operating in the US Urinary Incontinence Market?

    Key players in the US Urinary Incontinence Market include UroLift, Johnson and Johnson, Coloplast, and Medtronic among others.

    What is the anticipated market value for functional incontinence by 2035?

    The anticipated market value for functional incontinence in the US Urinary Incontinence Market is expected to reach 1.338 billion USD by 2035.

    How much is the overflow incontinence segment expected to be valued in 2035?

    The overflow incontinence segment is expected to be valued at 1.19 billion USD in 2035.

    What emerging trends are influencing the US Urinary Incontinence Market?

    Emerging trends in the US Urinary Incontinence Market include advancements in minimally invasive procedures and increased awareness about treatment options.

    What are the main growth drivers for the US Urinary Incontinence Market?

    Key growth drivers for the US Urinary Incontinence Market include the rising aging population and increased prevalence of urinary incontinence disorders.

    1. EXECUTIVE SUMMARY
    2. Market Overview
    3. Key Findings
    4. Market Segmentation
    5. Competitive Landscape
    6. Challenges and Opportunities
    7. Future Outlook
    8. MARKET INTRODUCTION
    9. Definition
    10. Scope of the study
    11. Research Objective
    12. Assumption
    13. Limitations
    14. RESEARCH METHODOLOGY
    15. Overview
    16. Data Mining
    17. Secondary Research
    18. Primary Research
    19. Primary Interviews and Information Gathering Process
    20. Breakdown of Primary Respondents
    21. Forecasting Model
    22. Market Size Estimation
    23. Bottom-Up Approach
    24. Top-Down Approach
    25. Data Triangulation
    26. Validation
    27. MARKET DYNAMICS
    28. Overview
    29. Drivers
    30. Restraints
    31. Opportunities
    32. MARKET FACTOR ANALYSIS
    33. Value chain Analysis
    34. Porter's Five Forces Analysis
    35. Bargaining Power of Suppliers
    36. Bargaining Power of Buyers
    37. Threat of New Entrants
    38. Threat of Substitutes
    39. Intensity of Rivalry
    40. COVID-19 Impact Analysis
    41. Market Impact Analysis
    42. Regional Impact
    43. Opportunity and Threat Analysis
    44. US Urinary Incontinence Market, BY Type (USD Billion)
    45. Urge incontinence
    46. Stress Incontinence
    47. Overflow incontinence
    48. Functional incontinence
    49. US Urinary Incontinence Market, BY Devices (USD Billion)
    50. Electrical Stimulation Devices
    51. Foley Catheters
    52. Antimicrobial Foley Catheters
    53. Urethral Bulking Agents
    54. Competitive Landscape
    55. Overview
    56. Competitive Analysis
    57. Market share Analysis
    58. Major Growth Strategy in the Urinary Incontinence Market
    59. Competitive Benchmarking
    60. Leading Players in Terms of Number of Developments in the Urinary Incontinence Market
    61. Key developments and growth strategies
    62. New Product Launch/Service Deployment
    63. Merger & Acquisitions
    64. Joint Ventures
    65. Major Players Financial Matrix
    66. Sales and Operating Income
    67. Major Players R&D Expenditure. 2023
    68. Company Profiles
    69. UroLift
    70. Financial Overview
    71. Products Offered
    72. Key Developments
    73. SWOT Analysis
    74. Key Strategies
    75. Hollister Incorporated
    76. Financial Overview
    77. Products Offered
    78. Key Developments
    79. SWOT Analysis
    80. Key Strategies
    81. Johnson and Johnson
    82. Financial Overview
    83. Products Offered
    84. Key Developments
    85. SWOT Analysis
    86. Key Strategies
    87. Coloplast
    88. Financial Overview
    89. Products Offered
    90. Key Developments
    91. SWOT Analysis
    92. Key Strategies
    93. Convatec
    94. Financial Overview
    95. Products Offered
    96. Key Developments
    97. SWOT Analysis
    98. Key Strategies
    99. Stryker Corporation
    100. Financial Overview
    101. Products Offered
    102. Key Developments
    103. SWOT Analysis
    104. Key Strategies
    105. Astellas Pharma
    106. Financial Overview
    107. Products Offered
    108. Key Developments
    109. SWOT Analysis
    110. Key Strategies
    111. Abbott Laboratories
    112. Financial Overview
    113. Products Offered
    114. Key Developments
    115. SWOT Analysis
    116. Key Strategies
    117. B Braun
    118. Financial Overview
    119. Products Offered
    120. Key Developments
    121. SWOT Analysis
    122. Key Strategies
    123. ConvaTec
    124. Financial Overview
    125. Products Offered
    126. Key Developments
    127. SWOT Analysis
    128. Key Strategies
    129. Boston Scientific
    130. Financial Overview
    131. Products Offered
    132. Key Developments
    133. SWOT Analysis
    134. Key Strategies
    135. Sofradim Production
    136. Financial Overview
    137. Products Offered
    138. Key Developments
    139. SWOT Analysis
    140. Key Strategies
    141. Medtronic
    142. Financial Overview
    143. Products Offered
    144. Key Developments
    145. SWOT Analysis
    146. Key Strategies
    147. Baxter International
    148. Financial Overview
    149. Products Offered
    150. Key Developments
    151. SWOT Analysis
    152. Key Strategies
    153. C.R. Bard
    154. Financial Overview
    155. Products Offered
    156. Key Developments
    157. SWOT Analysis
    158. Key Strategies
    159. References
    160. Related Reports
    161. US Urinary Incontinence Market SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD Billions)
    162. US Urinary Incontinence Market SIZE ESTIMATES & FORECAST, BY DEVICES, 2019-2035 (USD Billions)
    163. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
    164. ACQUISITION/PARTNERSHIP
    165. MARKET SYNOPSIS
    166. US URINARY INCONTINENCE MARKET ANALYSIS BY TYPE
    167. US URINARY INCONTINENCE MARKET ANALYSIS BY DEVICES
    168. KEY BUYING CRITERIA OF URINARY INCONTINENCE MARKET
    169. RESEARCH PROCESS OF MRFR
    170. DRO ANALYSIS OF URINARY INCONTINENCE MARKET
    171. DRIVERS IMPACT ANALYSIS: URINARY INCONTINENCE MARKET
    172. RESTRAINTS IMPACT ANALYSIS: URINARY INCONTINENCE MARKET
    173. SUPPLY / VALUE CHAIN: URINARY INCONTINENCE MARKET
    174. URINARY INCONTINENCE MARKET, BY TYPE, 2025 (% SHARE)
    175. URINARY INCONTINENCE MARKET, BY TYPE, 2019 TO 2035 (USD Billions)
    176. URINARY INCONTINENCE MARKET, BY DEVICES, 2025 (% SHARE)
    177. URINARY INCONTINENCE MARKET, BY DEVICES, 2019 TO 2035 (USD Billions)
    178. BENCHMARKING OF MAJOR COMPETITORS

    US Urinary Incontinence Market Segmentation

     

     

     

    • Urinary Incontinence Market By Type (USD Billion, 2019-2035)

      • Urge incontinence
      • Stress Incontinence
      • Overflow incontinence
      • Functional incontinence

     

    • Urinary Incontinence Market By Devices (USD Billion, 2019-2035)

      • Electrical Stimulation Devices
      • Foley Catheters
      • Antimicrobial Foley Catheters
      • Urethral Bulking Agents

     

     

     

     

     

     

    Report Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials